Tag: MHRA
Yellow Card System Transforms Patient Safety: How UK’s Medicine Regulator Uses Sports Metaphor to Boost Drug Reporting
The UK's MHRA is launching a public awareness campaign for its Yellow Card scheme, a voluntary adverse drug reaction reporting…
UK Medicines Regulator Upholds Advertising Standards: June 2026 Enforcement Actions
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published enforcement decisions on pharmaceutical advertisements investigated in June 2026…
UK Regulator Streamlines Drug Label Changes Via Self-Certification Model
The UK MHRA has published guidance permitting pharmaceutical manufacturers to submit non-safety-critical changes to drug labels and Patient Information Leaflets…
MHRA Safety Roundup: June 2026 — Key Drug and Device Alerts for Clinicians
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its June 2026 safety roundup, consolidating critical alerts for…
UK Medical Device Manufacturers Must Navigate New MHRA Registration System Post-Brexit
Medical device manufacturers must now register separately with the UK's MHRA for market access in Great Britain and Northern Ireland…
UK’s MHRA Launches Innovation Guidance to Accelerate Medical Device and Drug Development
The UK's MHRA has published formal guidance for drug and medical device developers, offering free access to regulatory expertise to…
MHRA publishes register of authorised online medicine sellers in Northern Ireland
The MHRA has published a searchable register of all websites authorised to sell medicines online in Northern Ireland, enabling patients…
UK’s MHRA Publishes Performance Data: Drug Approvals, Review Times, and Regulatory Efficiency Metrics
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has published comprehensive performance data on drug approvals, review timelines, and…